I have to admit I feel a bit uncomfortable now as you are also thinking that JAKK is a good investment. I will hold on to the MRGE long though as I could imagine the shares easily hitting $3 within a few weeks.
they would be very happy to get the underperforming Wolfson acquisition and an otherwise completely Apple-centric business with severe margin pressure I guess
no - but the Apple revenue level won't exactly move up going forward and even if they would be able to secure new business (which they haven't for years) with Apple it would come at expense of margins.
I have told so many times here I getting really tired, but: If you want to play Apple just buy APPLE, the shares aren't expensive even at all time highes. But don't stick with this measly supplier who has been losing slots consistently and faces severe margin pressure.
thanks - I got 15 years of experience with trading tech stocks - it is not that difficult - just look at CRUS or SIMO today
you are just riding the new IPhone generation tailwinds currently which will be gone going forward - and you have a brandnew acquisition already heavily backfiring on you
gross margins projected to move even lower next quarter while revenues will stay the same - company is going to evaluate their procedures to go after new contract signings to avoid more losses
you don't need to go further - the already stretched valuation prevents the shares from making strong moves regardless of the numbers. They would have to report absolutely blow-out numbers and an even stronger outlook to move the needle here. Would expect the shares to dip in the red later today.
The market cap of TASR is a whopping $900 mln compared to DGLY tiny $40 mln which makes their stock much easier to move.
With TASR trading at 5x expected FY15 revenues and 40x expected FY15 eps on an expected growth rate of below 15% the current share price looks pretty extended here.
despite much higher revenues the margins were actually lower than expected by you - given the commentary I wouldn't expect profitability anytime soon. Shorted.
good results were pretty much expected and are quite similar to the numbers reported six months ago. As in the past I don't expect the shares to move on the news.
Oppenheimer notes CRUS reported F2Q (Sep.) sales/EPS of $210M/$0.68, besting consensus' $188M/ $0.54E as the company benefited from strong AAPL sales and five weeks (~$13M) of WLF revenues. Mgmt guided F3Q (Dec.) revenues to $275M (vs. consensus est. $217M) on AAPL strength and a full quarter of WLF sales (~$25M). GM of 48.7% in September tracked modestly ahead of expectations; however, GMs are declining ~370bp to 45% in December as lower margin WLF folds into the mix and GMs at AAPL continue to compress. Additionally, CRUS will exhaust its US NOLs by March and is expected to become a 30% tax payer (vs 3% today) in CY15. Despite the strong top-line results and guidance, firm continues to see valuation extended at these levels.